Facial Moisturizer Recalled for Improper Storage Temperature Conditions
Family Dollar Stores is recalling AMBI Nursing Daily Facial Moisturizer 1.7 oz distributed nationwide from April 30 through June 10, 2022, because the product was held outside appropriate storage temperature conditions.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Product held outside appropriate storage conditions constitutes a risk-of-harm scenario. No illnesses or injuries have been reported. Per the severity rubric, this qualifies as High (3).
Plain-English summary
Family Dollar Stores, LLC is recalling AMBI Nursing Daily Facial Moisturizer 1.7 oz (SKU 2096628) that was distributed nationwide between April 30, 2022 and June 10, 2022.
The product is being recalled due to CGMP deviations: it was held outside appropriate storage temperature conditions during distribution.
Consumers who obtained this product should discontinue use.
The recalled product
- Product
- AMBI NRSHNG DAILY FACIAL MSTURZER 1.7 OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Skincare / Topical
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 2096628
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01